Episode Details

Back to Episodes

The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce

Episode 202 Published 2 years, 10 months ago

Description

A top biotech analyst looks beyond Eli Lilly and Novo Nordisk for weight loss investments. Jack talks stocks, bonds, rates, and crypto.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.